Delivery Order SPE2DB22D3301-SPE2DB25FY0VD
Award Date
2/28/25
Potential Completion Date
3/3/25
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of glycopyrrolate 1 mg/5 ml vials. The contract has a ceiling value of $1,867.08 and a period of performance through December 9, 2024. This Delivery Order is placed against an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of Glycopyrrolate 1 mg/5 ml vials, a medication used for various medical treatments. The contract has a ceiling value of $1,160.22 and runs through January 16, 2025. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Glycopyrrolate 0.2 mg/ml vials (2 ml) to support military healthcare programs. The contract is a firm fixed-price, delivery order with a ceiling value of $7,599.65 and a period of performance through March 4, 2024. The award is not designated as a set-aside contract. In...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GLYCOPYRROLATE 0.2 MG/ML VIAL 2ML, a medical product, with a ceiling value of $7,484.43 and a period of performance through May 30, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. This award is associated with a larger...
This is a delivery order (contract) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,341.26, is for the supply of glycopyrrolate 0.2 mg/ml vials (20 ml) to support military healthcare programs. The contract has a firm fixed price and an ultimate completion date of May 2, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,050.14, is for the delivery of 4 mg/20 ml vials of the medication glycopyrrolate. The contract has an ultimate completion date of January 23, 2025 and is a firm fixed-price contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $6,539.83, is for the supply of 4563402308 - Glycopyrrolate 0.5 mg/mL vials. The contract type is Firm Fixed Price and has an ultimate completion date of January 23, 2024. This order is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,254,915 units of the drug Glycopyrrolate 1 mg/5 ml vial, 5 ml, with a ceiling value of $1,495.28. It is a firm fixed-price delivery order contract with a completion date of September 9, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,147.21, is for the delivery of glycopyrrolate 0.2 mg/ml vials to support military and federal healthcare programs. The contract has a completion date of February 21, 2024 and is a firm fixed-price delivery order. No set-aside designation was used....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4565616879 - GLYCOPYRROLATE 0.2 MG/ML VIAL 5ML. The contract has an ultimate completion date of August 29, 2024 and a ceiling value of $15,536.46. The contract is not set aside. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range of medical commodities, including specialty...